{"DataElement":{"publicId":"2756917","version":"1","preferredName":"Serum Immunologic Laboratory Procedure Performed Type","preferredDefinition":"A description of the serum immunologic laboratory procedure performed.","longName":"SRIMM_LBPR_PRF_TP","context":"NHLBI","contextVersion":"1","DataElementConcept":{"publicId":"2756913","version":"1","preferredName":"Serum Immunologic Laboratory Procedure Performed","preferredDefinition":"Pertaining to serologic tests to determine the presence of immunologic factors or evidence of an immune response._Any procedure that involves testing or manipulating a sample of blood, urine, or other body substance in a laboratory setting._Executed and carried through to completion.","longName":"IMMUN_LAB_PRC_PRF","context":"NHLBI","contextVersion":"1","ObjectClass":{"publicId":"2936124","version":"1","preferredName":"Serum Immunologic Laboratory Procedure","preferredDefinition":"Serum Immunologic; refers to immunologic features of or immunologic tests done on serum.:Any procedure that involves testing or manipulating a sample of blood, urine, or other body substance in a laboratory setting.","longName":"C25675:C25294","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Serum Immunologic","conceptCode":"C25675","definition":"Pertaining to serologic tests to determine the presence of immunologic factors or evidence of an immune response.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Laboratory Procedure","conceptCode":"C25294","definition":"Any procedure that involves testing or manipulating a sample of blood, urine, or other body substance in a laboratory setting.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"720EDCB1-6BF5-5FCA-E040-BB89AD4346AD","latestVersionIndicator":"Yes","beginDate":"2009-08-26","endDate":null,"createdBy":"NYCHM","dateCreated":"2009-08-26","modifiedBy":"ONEDATA","dateModified":"2009-08-26","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2241241","version":"1","preferredName":"Performed","preferredDefinition":"Performed; carried out.","longName":"C38000","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Performed","conceptCode":"C38000","definition":"Executed and carried through to completion.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F9FA7953-8839-043D-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-07-08","endDate":null,"createdBy":"SHIDED","dateCreated":"2005-07-08","modifiedBy":"ONEDATA","dateModified":"2005-07-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008557","version":"1","preferredName":"Lab Results","preferredDefinition":"the results of laboratory tests.","longName":"LAB_RESULTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2CFBA7D-D009-7227-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-27","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"4EF25FC4-7276-69A1-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-06-05","endDate":null,"createdBy":"NYCHM","dateCreated":"2008-06-05","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":".","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2756915","version":"1","preferredName":"Immunology Laboratory Procedure Type","preferredDefinition":"The study of the immune system and its reaction to pathogens, as well as its malfunctions (autoimmune diseases, allergies, rejection of organ transplants)._Any procedure that involves testing or manipulating a sample of blood, urine, or other body substance in a laboratory setting.Type; a subdivision of a particular kind of thing.","longName":"IMMUN_LP_TYP","context":"NHLBI","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"60","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"IgG","valueDescription":"IgG","ValueMeaning":{"publicId":"2658037","version":"1","preferredName":"IgG","longName":"2658037","preferredDefinition":"An immunoglobulin isotype (subclass) that characterizes secondary immune responses.  This isotype is further broken down into several smaller subclasses (IgG1, IgG2a, IgG2b, IgG3 in the mouse; IgG1-4 in the human), and each subclass is differentially synthesized and secreted into the serum upon differential immune stimuli.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"IgG","conceptCode":"C568","definition":"An immunoglobulin isotype (subclass) that characterizes secondary immune responses.  This isotype is further broken down into several smaller subclasses (IgG1, IgG2a, IgG2b, IgG3 in the mouse; IgG1-4 in the human), and each subclass is differentially synthesized and secreted into the serum upon differential immune stimuli.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3356EC85-90C0-2A59-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-06-20","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2007-06-20","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4EF18CA1-A92C-6F09-E044-0003BA3F9857","beginDate":"2008-06-05","endDate":null,"createdBy":"NYCHM","dateCreated":"2008-06-05","modifiedBy":"NYCHM","dateModified":"2008-06-05","deletedIndicator":"No"},{"value":"IgM","valueDescription":"IgM","ValueMeaning":{"publicId":"2568587","version":"1","preferredName":"IgM","longName":"2568587","preferredDefinition":"The major immunoglobulin secreted during a primary immune response.  IgM binds with low affinity but high avidity (multiple binding sites) because it not only occurs as monomers but also as pentamers and hexamers.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"IgM","conceptCode":"C569","definition":"The major immunoglobulin secreted during a primary immune response.  IgM binds with low affinity but high avidity (multiple binding sites) because it not only occurs as monomers but also as pentamers and hexamers.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D8F8-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-02-25","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-02-25","modifiedBy":"CHILLIJ","dateModified":"2007-06-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4EF18CA1-A938-6F09-E044-0003BA3F9857","beginDate":"2008-06-05","endDate":null,"createdBy":"NYCHM","dateCreated":"2008-06-05","modifiedBy":"NYCHM","dateModified":"2008-06-05","deletedIndicator":"No"},{"value":"IgA","valueDescription":"IgA","ValueMeaning":{"publicId":"2658038","version":"1","preferredName":"IgA","longName":"2658038","preferredDefinition":"IgA is the immunoglobulin subclass that is associated with antibody-mediated mucosal immunity.  It is secreted as dimers into the mucosa and is the most effective isotype at fixing complement by the alternative pathway, even though it lacks the ability to fix complement by the classical pathway. There are two subtypes in the human - IgA1 and IgA2.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"IgA","conceptCode":"C565","definition":"IgA is the immunoglobulin subclass that is associated with antibody-mediated mucosal immunity.  It is secreted as dimers into the mucosa and is the most effective isotype at fixing complement by the alternative pathway, even though it lacks the ability to fix complement by the classical pathway. There are two subtypes in the human - IgA1 and IgA2.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3356EC85-90E4-2A59-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-06-20","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2007-06-20","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4EF18CA1-A944-6F09-E044-0003BA3F9857","beginDate":"2008-06-05","endDate":null,"createdBy":"NYCHM","dateCreated":"2008-06-05","modifiedBy":"NYCHM","dateModified":"2008-06-05","deletedIndicator":"No"},{"value":"T-cell function","valueDescription":"T-Lymphocyte Function","ValueMeaning":{"publicId":"2815217","version":"1","preferredName":"T-Lymphocyte Function","longName":"2815217","preferredDefinition":"One type of white blood cell that attacks virus-infected cells, foreign cells, and cancer cells.  T cells also produce a number of substances that regulate the immune response.: Function; what something is used for.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"T-Lymphocyte","conceptCode":"C12476","definition":"A thymocyte-derived lymphocyte of immunological importance that is long-lived (months to years) and is responsible for cell-mediated immunity. T lymphocyte cells form rosettes with sheep erythrocytes and, in the presence of transforming agents (mitogens), differentiate and divide. These cells have the characteristic T3 surface marker and may be further divided into subsets according to function, such as helper, cytotoxic, etc.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Function","conceptCode":"C25518","definition":"The normal action performed by a structure or device.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"5DCBD719-6304-D419-E040-BB89A6432E6B","latestVersionIndicator":"Yes","beginDate":"2008-12-11","endDate":null,"createdBy":"NYCHM","dateCreated":"2008-12-11","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"5DCBD719-631D-D419-E040-BB89A6432E6B","beginDate":"2008-12-11","endDate":null,"createdBy":"CDECURATE","dateCreated":"2008-12-11","modifiedBy":"CDECURATE","dateModified":"2008-12-11","deletedIndicator":"No"},{"value":"Natural killer cell activity","valueDescription":"Natural Killer Cell Activity","ValueMeaning":{"publicId":"2815218","version":"1","preferredName":"Natural Killer Cell Activity","longName":"2815218","preferredDefinition":"White blood cells that attack tumor cells and body cells that have been invaded by foreign substances.: The state of being active; any specific activity.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Natural Killer Cell","conceptCode":"C12536","definition":"Natural killer cells are cells that resemble large granular lymphocytes.  They do not express markers of either T or B cell lineage. They are positive for CD16, CD56, and CD 94.  These cells do possess Fc receptors for IgG and can kill target cells using antibody-dependent cell-mediated cytotoxicity. They can also use perforin to kill cells in the absence of antibody and killing may occur without previous sensitization.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Activity","conceptCode":"C43431","definition":"An active process; excludes processes and mechanisms which fulfill biological functions.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"5DCBD719-632C-D419-E040-BB89A6432E6B","latestVersionIndicator":"Yes","beginDate":"2008-12-11","endDate":null,"createdBy":"NYCHM","dateCreated":"2008-12-11","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"5DCBD719-6345-D419-E040-BB89A6432E6B","beginDate":"2008-12-11","endDate":null,"createdBy":"CDECURATE","dateCreated":"2008-12-11","modifiedBy":"CDECURATE","dateModified":"2008-12-11","deletedIndicator":"No"},{"value":"Granulocyte chemotaxis","valueDescription":"Granulocyte Chemotaxis","ValueMeaning":{"publicId":"2815219","version":"1","preferredName":"Granulocyte Chemotaxis","longName":"2815219","preferredDefinition":"A leucocyte with conspicuous cytoplasmic granules. In humans the granulocytes are also classified as polymorphonuclear leucocytes and are subdivided according to the staining properties of the granules into eosinophils, basophils and neutrophils. (from On-line Medical Dictionary): The characteristic directional movement or orientation of an organism or cell along a chemical concentration gradient either toward or away from the chemical stimulus.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Granulocyte","conceptCode":"C12530","definition":"A type of leukocyte with a multilobed nucleus and cytoplasmic granules. The unique morphology of the nucleus has led to their also being known as polymorphonuclear leukocytes (PMLs or PMNs). Granulocytes are subdivided according to the staining properties of their granules into eosinophils (red with acidic dye), basophils (blue with basic dye), and neutrophils (not amenable to staining with either acidic or basic dyes).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Chemotactic Process","conceptCode":"C16422","definition":"The characteristic directional movement or orientation of an organism or cell along a chemical concentration gradient either toward or away from the chemical stimulus.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"5DCBD719-6354-D419-E040-BB89A6432E6B","latestVersionIndicator":"Yes","beginDate":"2008-12-11","endDate":null,"createdBy":"NYCHM","dateCreated":"2008-12-11","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"5DCBD719-636D-D419-E040-BB89A6432E6B","beginDate":"2008-12-11","endDate":null,"createdBy":"CDECURATE","dateCreated":"2008-12-11","modifiedBy":"CDECURATE","dateModified":"2008-12-11","deletedIndicator":"No"},{"value":"Cytotoxic T-cell activity","valueDescription":"Cytotoxic T-Lymphocyte Activity","ValueMeaning":{"publicId":"2815221","version":"1","preferredName":"Cytotoxic T-Lymphocyte Activity","longName":"2815221","preferredDefinition":"Immunized T-lymphocytes which can directly destroy appropriate target cells. These cytotoxic lymphocytes may be generated in vitro in mixed lymphocyte cultures (MLC), in vivo during a graft-versus-host (GVH) reaction, or after immunization with an allograft, tumor cell or virally transformed or chemically modified target cell. These cells are distinct from natural killer cells and from killer cells mediating antibody-dependent cell cytotoxicity.: The state of being active; any specific activity.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cytotoxic T-Lymphocyte","conceptCode":"C12543","definition":"Immunized T-lymphocytes which can directly destroy appropriate target cells. These cytotoxic lymphocytes may be generated in vitro in mixed lymphocyte cultures (MLC), in vivo during a graft-versus-host (GVH) reaction, or after immunization with an allograft, tumor cell or virally transformed or chemically modified target cell. These cells are distinct from natural killer cells and from killer cells mediating antibody-dependent cell cytotoxicity.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Activity","conceptCode":"C43431","definition":"An active process; excludes processes and mechanisms which fulfill biological functions.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"5DCBD719-637D-D419-E040-BB89A6432E6B","latestVersionIndicator":"Yes","beginDate":"2008-12-11","endDate":null,"createdBy":"NYCHM","dateCreated":"2008-12-11","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"5DCBD719-6396-D419-E040-BB89A6432E6B","beginDate":"2008-12-11","endDate":null,"createdBy":"CDECURATE","dateCreated":"2008-12-11","modifiedBy":"CDECURATE","dateModified":"2008-12-11","deletedIndicator":"No"},{"value":"IgE","valueDescription":"IgE","ValueMeaning":{"publicId":"2658040","version":"1","preferredName":"IgE","longName":"2658040","preferredDefinition":"An immunoglobulin isotype (subclass).  This isotype has the unique ability to bind with high affinity to IgE receptors (FceRI) on mast cells and basophils and induce degranulation and cytokine production by these cells when they are crosslinked by antigen.  In addition to a central role in atopy and allergic responses, it has been speculated that IgE-mediated mast cell degranulation, by its release of mediators that increase vascular permeability, has an important role in the initiation of immune response in general.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"IgE","conceptCode":"C567","definition":"An immunoglobulin isotype (subclass).  This isotype has the unique ability to bind with high affinity to IgE receptors (FceRI) on mast cells and basophils and induce degranulation and cytokine production by these cells when they are crosslinked by antigen.  In addition to a central role in atopy and allergic responses, it has been speculated that IgE-mediated mast cell degranulation, by its release of mediators that increase vascular permeability, has an important role in the initiation of immune response in general.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3356EC85-914C-2A59-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-06-20","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2007-06-20","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":"Updated Definition/Description to match NCIt.  Added text \"In addition to...  ...response in general.\" mcolbert 1/9/2014","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"5DCBD719-63A2-D419-E040-BB89A6432E6B","beginDate":"2008-12-11","endDate":null,"createdBy":"CDECURATE","dateCreated":"2008-12-11","modifiedBy":"CDECURATE","dateModified":"2008-12-11","deletedIndicator":"No"},{"value":"T-cell numbers / subsets","valueDescription":"T-Lymphocyte Count","ValueMeaning":{"publicId":"2815222","version":"1","preferredName":"T-Lymphocyte Count","longName":"2815222","preferredDefinition":"One type of white blood cell that attacks virus-infected cells, foreign cells, and cancer cells.  T cells also produce a number of substances that regulate the immune response.: To determine the number or amount of something; the result of this activity.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"T-Lymphocyte","conceptCode":"C12476","definition":"A thymocyte-derived lymphocyte of immunological importance that is long-lived (months to years) and is responsible for cell-mediated immunity. T lymphocyte cells form rosettes with sheep erythrocytes and, in the presence of transforming agents (mitogens), differentiate and divide. These cells have the characteristic T3 surface marker and may be further divided into subsets according to function, such as helper, cytotoxic, etc.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Count","conceptCode":"C25463","definition":"Determining the number or amount of something.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"5DCAAC7C-67F7-4858-E040-BB89A6432A2D","latestVersionIndicator":"Yes","beginDate":"2008-12-11","endDate":null,"createdBy":"NYCHM","dateCreated":"2008-12-11","modifiedBy":"ONEDATA","dateModified":"2008-12-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"5DCAAC7C-6810-4858-E040-BB89A6432A2D","beginDate":"2008-12-11","endDate":null,"createdBy":"CDECURATE","dateCreated":"2008-12-11","modifiedBy":"CDECURATE","dateModified":"2008-12-11","deletedIndicator":"No"},{"value":"unknown","valueDescription":"Unknown","ValueMeaning":{"publicId":"2575365","version":"1","preferredName":"Unknown","longName":"2575365","preferredDefinition":"Not known, not observed, not recorded, or refused.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Unknown","conceptCode":"C17998","definition":"Not known, observed, recorded; or reported as unknown by the data contributor.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-F372-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-15","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"MMADDINENI","dateModified":"2024-01-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"828F858A-3F47-C603-E040-BB89AD4303BC","beginDate":"2010-03-24","endDate":null,"createdBy":"ZHANGW","dateCreated":"2010-03-24","modifiedBy":"ONEDATA","dateModified":"2010-03-24","deletedIndicator":"No"},{"value":"IgD","valueDescription":"IgD","ValueMeaning":{"publicId":"2658039","version":"1","preferredName":"IgD","longName":"2658039","preferredDefinition":"An immunoglobulin isotype (subclass).  This isotype is expressed on naive B cells along with IgM.  Little is known about its physiologic role.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"IgD","conceptCode":"C566","definition":"An immunoglobulin isotype (subclass).  This isotype is expressed on naive B cells along with IgM.  Little is known about its physiologic role.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3356EC85-9126-2A59-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-06-20","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2007-06-20","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"828F858A-3F51-C603-E040-BB89AD4303BC","beginDate":"2010-03-24","endDate":null,"createdBy":"ZHANGW","dateCreated":"2010-03-24","modifiedBy":"ONEDATA","dateModified":"2010-03-24","deletedIndicator":"No"},{"value":"B-cells (CD19+, CD20+, sIg+)","valueDescription":"B-Lymphocyte","ValueMeaning":{"publicId":"2581328","version":"1","preferredName":"B-Lymphocyte","longName":"2581328","preferredDefinition":"Lymphoid cells concerned with humoral immunity. They are short-lived cells resembling bursa-derived lymphocytes of birds in their production of immunoglobulin upon appropriate stimulation.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"B-Lymphocyte","conceptCode":"C12474","definition":"Immunologically important lymphocyte that is not thymus-dependent, is either short-lived and naive or long-lived and of memory phenotype, and resembles the bursa-derived lymphocyte of birds in that it is responsible for the production of immunoglobulins.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-0ABD-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-10-24","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2006-10-24","modifiedBy":"ONEDATA_WA","dateModified":"2023-02-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","id":"7A391AEC-0456-397F-E040-BB89AD430848","beginDate":"2009-12-08","endDate":null,"createdBy":"LOHNESC","dateCreated":"2009-12-08","modifiedBy":"ONEDATA","dateModified":"2009-12-08","deletedIndicator":"No"},{"value":"CD8+ cells","valueDescription":"CD8 Antigen, Beta Polypeptide 1","ValueMeaning":{"publicId":"2802768","version":"1","preferredName":"CD8 Antigen, Beta Polypeptide 1","longName":"2802768","preferredDefinition":"suppressor T-lymphocyte marker that functions as a receptor for MHC class I antigen.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"T-Cell Surface Glycoprotein CD8 Beta Chain","conceptCode":"C17441","definition":"T-cell surface glycoprotein CD8 beta chain (210 aa, ~24 kDa) is encoded by the human CD8B gene. This protein plays a role in T-cell cytotoxicity.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"5C0CC8E4-767A-2D77-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"NYCHM","dateCreated":"2008-11-19","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","id":"7A391AEC-046A-397F-E040-BB89AD430848","beginDate":"2009-12-08","endDate":null,"createdBy":"LOHNESC","dateCreated":"2009-12-08","modifiedBy":"ONEDATA","dateModified":"2009-12-08","deletedIndicator":"No"},{"value":"CD4+ cells","valueDescription":"CD4 Antigen","ValueMeaning":{"publicId":"2802762","version":"1","preferredName":"CD4 Antigen","longName":"2802762","preferredDefinition":"CD4 Antigen, encoded by the CD4 gene, is a T-cell surface glycoprotein. CD4 has a role in cell-cell interactions and may act in signal transduction. CD4 is a accessory protein for MHC class-II antigen/T-cell receptor interaction and functions to initiate or augment the early phase of T-cell activation. CD4 enhances T-cell sensitivity to antigen and binds to LCK, which phosphorylates CD3-zeta. CD4 Antigen also serves as an HIV receptor, binding directly to the envelope protein gp120 on HIV. (From LocusLink, OMIM and NCI)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"T-Cell Surface Glycoprotein CD4","conceptCode":"C16300","definition":"T-cell surface glycoprotein CD4 (458 aa, ~51 kDa) is encoded by the human CD4 gene. This protein plays a role in antigen recognition and HIV entry.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"5C0CC8E4-762C-2D77-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"NYCHM","dateCreated":"2008-11-19","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","id":"7A391AEC-047E-397F-E040-BB89AD430848","beginDate":"2009-12-08","endDate":null,"createdBy":"LOHNESC","dateCreated":"2009-12-08","modifiedBy":"ONEDATA","dateModified":"2009-12-08","deletedIndicator":"No"},{"value":"Other immunologic evaluation","valueDescription":"Other Serum Immunologic Evaluation","ValueMeaning":{"publicId":"4826695","version":"1","preferredName":"Other Serum Immunologic Evaluation","longName":"4826695","preferredDefinition":"Different than the one(s) previously specified or mentioned.: Pertaining to serologic tests to determine the presence of immunologic factors or evidence of an immune response.: Systematic, objective appraisal of the significance, effectiveness, and impact of activities or condition according to specified objectives and criteria.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Serum Immunologic","conceptCode":"C25675","definition":"Pertaining to serologic tests to determine the presence of immunologic factors or evidence of an immune response.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Evaluation","conceptCode":"C25214","definition":"Systematic, objective appraisal of the significance, effectiveness, and impact of activities or condition according to specified objectives and criteria.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"16209366-549D-AFB4-E050-BB89AD435F28","latestVersionIndicator":"Yes","beginDate":"2015-05-15","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2015-05-15","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"16209366-54B6-AFB4-E050-BB89AD435F28","beginDate":"2015-05-15","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2015-05-15","modifiedBy":"ONEDATA","dateModified":"2015-05-15","deletedIndicator":"No"},{"value":"No immunoglobulin testing performed","valueDescription":"Immunoglobulin Testing Not Performed","ValueMeaning":{"publicId":"7613869","version":"1","preferredName":"Immunoglobulin Testing Not Performed","longName":"7613869","preferredDefinition":"Any of the structurally related glycoproteins that function as antibodies. They are divided into five classes (IGA, IGD, IGE, IGG, IGM) on the basis of structure and biological activity.: A procedure for critical evaluation.: An indicator that specifies that an activity did not occur.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Immunoglobulin","conceptCode":"C572","definition":"Any of the structurally related glycoproteins that function as antibodies. They are divided into five classes (IGA, IGD, IGE, IGG, IGM) on the basis of structure and biological activity.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Testing","conceptCode":"C15336","definition":"A procedure for critical evaluation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Not Performed","conceptCode":"C141477","definition":"An indicator that specifies that an activity did not occur.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BE4B30F0-8A00-4621-E053-4EBD850AC7F7","latestVersionIndicator":"Yes","beginDate":"2021-03-24","endDate":null,"createdBy":"MALUMK","dateCreated":"2021-03-24","modifiedBy":"ONEDATA","dateModified":"2021-03-24","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BE4B30F0-8A19-4621-E053-4EBD850AC7F7","beginDate":"2021-03-24","endDate":null,"createdBy":"MALUMK","dateCreated":"2021-03-24","modifiedBy":"ONEDATA","dateModified":"2021-03-24","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2435011","version":"1","preferredName":"Anatomic Structure, System, or Substance","preferredDefinition":"Body tissue, region, surface, cavity, fluid, organ, or collection of organs.","longName":"C12219","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741AE5B-831D-25C7-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2815216","version":"1","preferredName":"Immunology Laboratory Procedure Type","preferredDefinition":"The study of the body's immune system.:A medical procedure that involves testing a sample of blood, urine, or other substance from the body. Tests can help determine a diagnosis, plan treatment, check to see if treatment is working, or monitor the disease over time.:Type; a subdivision of a particular kind of thing.","longName":"C18011:C25294:C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Immunology","conceptCode":"C18011","definition":"The study of the immune system and its reaction to pathogens, as well as its malfunctions (autoimmune diseases, allergies, rejection of organ transplants).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Laboratory Procedure","conceptCode":"C25294","definition":"Any procedure that involves testing or manipulating a sample of blood, urine, or other body substance in a laboratory setting.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"5DCBD719-62D2-D419-E040-BB89A6432E6B","latestVersionIndicator":"Yes","beginDate":"2008-12-11","endDate":null,"createdBy":"NYCHM","dateCreated":"2008-12-11","modifiedBy":"ONEDATA","dateModified":"2008-12-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"4EF18CA1-A917-6F09-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-06-05","endDate":null,"createdBy":"NYCHM","dateCreated":"2008-06-05","modifiedBy":"MALUMK","dateModified":"2021-03-24","changeDescription":".Added PV for 2134r1. AK 5/15/15. PV added for 2100r7. 03/24/2021 KMM","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2695319","version":"1","longName":"NMDP: CDEs to review","context":"NHLBI","ClassificationSchemeItems":[{"publicId":"3234637","version":"1","longName":"2131r2: Immune Deficiencies Post-HSCT Data","context":"NHLBI"},{"publicId":"2964922","version":"1","longName":"2200r1: 6 Month to 2 Year Post-HSCT Data","context":"NHLBI"},{"publicId":"2964902","version":"1","longName":"2100r1: 100 Days Post-HSCT Data","context":"NHLBI"},{"publicId":"2964888","version":"1","longName":"2016r1: Myeloma Pre-HSCT Data","context":"NHLBI"},{"publicId":"2964897","version":"1","longName":"2031r1: Immune Deficiencies Pre-HSCT Data","context":"NHLBI"},{"publicId":"2964889","version":"1","longName":"2017r1: Amyloidosis Pre-HSCT Data","context":"NHLBI"},{"publicId":"3638517","version":"1","longName":"2031r2: Immune Deficiencies Pre-HSCT Data","context":"NHLBI"}]},{"publicId":"2842777","version":"1","longName":"Labs","context":"NHLBI","ClassificationSchemeItems":[{"publicId":"10000685","version":"1","longName":"General","context":"NHLBI"}]},{"publicId":"3553940","version":"1","longName":"BRIDG","context":"NHLBI","ClassificationSchemeItems":[{"publicId":"4133055","version":"1","longName":"Version 3.2","context":"NHLBI"}]},{"publicId":"6685474","version":"1","longName":"Artificial Neural Network Algorithm for BRIDG Mapping","context":"NCIP","ClassificationSchemeItems":[{"publicId":"6685476","version":"1","longName":"Training Set","context":"NCIP"}]}],"AlternateNames":[{"name":"Alliance","type":"USED_BY","context":"Alliance"},{"name":" DefinedProcedure:nameCode","type":"HCT_BRIDG","context":"NHLBI"},{"name":"HPST_IR_known_Ig_value_type","type":"NMDP_FN","context":"NHLBI"}],"ReferenceDocuments":[{"name":"Type of immunologic laborator","type":"Preferred Question Text","description":"Type of immunologic laboratory procedure performed:","url":null,"context":"NHLBI"},{"name":"Specify heavy chain type(s) present:","type":"Alternate Question Text","description":"Specify heavy chain type(s) present:","url":null,"context":"NHLBI"},{"name":"Type of immunologic laboratory procedure performed:","type":"Alternate Question Text","description":"Type of immunologic laboratory procedure performed:","url":null,"context":"NHLBI"},{"name":"BRIDG mapping path for CDE:2756917","type":"BRIDG Mapping Path","description":"PerformedProcedure > DefinedProcedure.nameCode WHERE DefinedProcedure.nameCode = \"Perform immunologic Analysis\"","url":null,"context":"NHLBI"},{"name":"What immunoglobulin testing was performed?","type":"Alternate Question Text","description":"What immunoglobulin testing was performed?","url":null,"context":"NHLBI"},{"name":"Specify the following serum quantitative immunoglobulins","type":"Alternate Question Text","description":"Specify the following serum quantitative immunoglobulins","url":null,"context":"NHLBI"},{"name":"CRF Text1","type":"Alternate Question Text","description":"Immunoglobulins","url":null,"context":"Alliance"},{"name":"Select all known immunoglobulin values","type":"Alternate Question Text","description":"Select all known immunoglobulin values","url":null,"context":"NHLBI"},{"name":"NMDP Text 1","type":"Alternate Question Text","description":"Select all known immunoglobulin (Ig) values","url":null,"context":"NHLBI"}],"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"4EF1A997-E4CE-73F4-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-06-05","endDate":null,"createdBy":"NYCHM","dateCreated":"2008-06-05","modifiedBy":"KUMMEROA","dateModified":"2022-05-16","changeDescription":".10/19/12 wz: added AQT to match F2013. Added CSIs 2031/2131r2.  AK 12/7/12 Added human readable def. System generated def displayed as alt def. No version needed. AK 10/26/14 Refreshed CDE after adding PV. AK 5/15/15. AQT added for 2100r7. 03/24/2021 KMM. ALT name added for 2100r7. 10/04/2021 KMM","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}